[Staged treatment of patients with severe hepatic alcoholic affection].
Pekhtashev
S G
SG
D020268:Alcohol-Induced Disorders, Nervous System / Q000188:drug therapy; D001202:Ascitic Fluid / Q000188:drug therapy; D006470:Hemorrhage / Q000188:drug therapy; D006519:Hepatitis, Alcoholic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007565:Jaundice / Q000188:drug therapy; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008887:Military Medicine; D010713:Phosphatidylcholines / Q000627:therapeutic use; D011379:Prognosis; D020011:Protective Agents / Q000627:therapeutic use; D012426:Russia; D012436:S-Adenosylmethionine / Q000627:therapeutic use; D012838:Silymarin / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D010713:Phosphatidylcholines; D020011:Protective Agents; D012838:Silymarin; D014803:Vitamin B Complex; D012436:S-Adenosylmethionine